Analyst Ratings for Ligand Pharma (LGND)
LGND Rating Summary
LGND Price Target Summary
- Highest: $388.00 (BofA Securities)
- Lowest: $282.00 (Citi)
- Average: $322.63
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$322.63 (+6.3%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
Avg. $ Target:
$322.63 (+6.3%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2026 | Oppenheimer | Leland Gershell | New Coverage | Outperform (N/A) |
285.00 (N/A) |
227.44 (303.39) |
33.39% | Details |
| 3/11/2026 | BofA Securities » Updated 7/9/2026 |
Jason Zemansky | New Coverage | Buy (N/A) |
388.00 (266.00) |
212.29 (303.39) |
42.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
